Category: Akari

  • Akari begins late-stage trial of nomacopan for Bullous Pemphigoid

    Akari Therapeutics is to begin a late-stage trial of nomacopan, its potential therapy for Bullous Pemphigoid, the rare autoimmune skin disorder. The company based in New York and London has clearance from the FDA to start development of the drug, with clinical sites due to open midway through this year. BP may last several years […]